Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · IEX Real-Time Price · USD
49.33
+0.46 (0.94%)
At close: Jul 19, 2024, 4:00 PM
49.27
-0.06 (-0.12%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

Astrana Health Revenue

Astrana Health had revenue of $1.45B in the twelve months ending March 31, 2024, with 19.34% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $404.36M with 19.90% year-over-year growth. In the year 2023, Astrana Health had annual revenue of $1.39B with 21.19% growth.

Revenue (ttm)
$1.45B
Revenue Growth
+19.34%
P/S Ratio
1.73
Revenue / Employee
$807,652
Employees
1,800
Market Cap
2.52B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.39B242.50M21.19%
Dec 31, 20221.14B370.25M47.84%
Dec 31, 2021773.92M86.74M12.62%
Dec 31, 2020687.18M126.56M22.58%
Dec 31, 2019560.62M40.71M7.83%
Dec 31, 2018519.91M163.55M45.90%
Dec 31, 2017356.36M50.42M16.48%
Dec 31, 2016305.93M272.95M827.36%
Mar 31, 201532.99M22.51M214.66%
Jan 31, 201410.48M2.71M34.83%
Jan 31, 20137.78M2.67M52.15%
Jan 31, 20125.11M1.21M31.16%
Jan 31, 20113.90M1.46M59.60%
Jan 31, 20102.44M1.38M130.90%
Jan 31, 20091.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardent Health Partners 5.53B
Integra LifeSciences Holdings 1.53B
Progyny 1.11B
PTC Therapeutics 927.56M
Certara 360.69M
Vericel 207.78M
Kymera Therapeutics 79.41M
Agios Pharmaceuticals 29.40M
Revenue Rankings